Actelion Stock Deutsche Boerse AG

Stocks

17-07-31	Actelion : France's Sanofi raises earnings forecast, pleased with eczema drug uptake	RE
17-07-18	Johnson & Johnson : J&J sees sales growth in near-term; raises 2017 profit forecast	RE
17-07-18	Johnson & Johnson : J&J sees sales growth in near-term; raises 2017 profit forecast	RE
17-06-09	Actelion : Johnson & Johnson expects to complete Actelion purchase on June 16	RE
17-06-09	Actelion : Johnson & Johnson expects to complete Actelion purchase on June 16	RE
17-06-09	Actelion : Johnson & Johnson expects to complete of Actelion offer on June 16	RE
17-05-22	Akzo Nobel : Cross-border M&A between U.S. and European firms at 10 year high	RE
17-05-18	Actelion : Johnson & Johnson offers EU concessions over Actelion deal	RE
17-04-20	Actelion : Johnson & Johnson target Actelion could exit Swiss benchmark SMI index this month	RE
17-04-18	Actelion : Johnson & Johnson first quarter revenue misses estimates; new forecast includes Actelion	RE
17-04-05	Actelion : shareholders back R&D spinoff, keep J&J deal on track	RE
17-03-31	Actelion : J&J declares Actelion tender offer a success, sees closing in second quarter	RE
17-02-22	Genmab A/S : and J&J's cancer drug set for blockbuster sales this year	RE

20-04-06	Actelion : Pharmaceuticals US, Inc, - Results from Expert Delphi Consensus Survey on Treatment of Pulmonary Arterial Hypertension with Oral Prostacyclin Pathway Agents	AQ
17-10-31	Actelion : Cancellation of publicly held Actelion shares and delisting from SIX Swiss Exchange as of November 7, 2017	GL
17-06-30	Actelion : Befreiung von Publizitätspflichten zur Aufrechterhaltung der Kotierung	GL
17-06-16	Actelion : Johnson & Johnson Completes Acquisition of Actelion	GL
17-06-15	Actelion : Publication of Idorsia's prospectus relating to the listing of Idorsia Ltd on SIX Swiss Exchange	PU

18-01-29	Après Bioverativ, Sanofi s'empare de la biotech belge Ablynx pour 3,9 mrd EUR
18-01-29	Après Bioverativ, Sanofi rachète la biotech belge Ablynx pour 3,9 mrd EUR
18-01-22	Avec Bioverativ, Sanofi devient un leader mondial dans l'hémophilie
17-10-31	Actelion : Cancellation of publicly held Actelion shares and delisting from SIX Swiss Exchange as of November 7, 2017
17-10-30	Actelion: la décotation est agendée au 7 novembre

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ACTELION	-.--%	-.--%	-	-	0
ARGENX SE	-1.86%	-4.39%	+45.64%	+66.74%	55.2B
WUXI APPTEC CO., LTD.	+2.83%	+0.48%	+28.18%	+82.59%	55.6B
BIONTECH SE	+0.54%	+1.22%	-16.62%	-13.47%	23.51B
INSMED INCORPORATED	-0.97%	-3.30%	-1.79%	+383.00%	22.35B
WUXI BIOLOGICS (CAYMAN) INC.	-4.01%	-3.67%	+13.17%	-14.29%	20.6B
GENMAB A/S	-0.87%	-2.60%	+26.72%	-33.46%	17.45B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-3.34%	-7.77%	+23.78%	+536.66%	15.16B
EXELIXIS, INC.	-2.09%	+0.64%	+49.78%	+178.74%	13.91B
PHARMAESSENTIA CORPORATION	-3.14%	-8.47%	+165.37%	+292.18%	13.74B
Average	-1.27%	-1.27%	+37.14%	+164.30%	26.39B
Weighted average by Cap.	-0.71%	-0.52%	+32.49%	+127.48%